Transdermal Delivery of Sumatriptan for the Treatment of Acute Migraine

Neurotherapeutics

Volumn 7, Issue 2, 2010, Pages 159-163

  Pierce, Mark W ^a  

^a NuPathe Inc   (United States)

Author keywords

Iontophoresis; migraine; sumatriptan; transdermal; Zelrix

Indexed keywords

4 (2 HYDROXYETHYL) 1 PIPERAZINEETHANESULFONIC ACID; BISABOLOL; CINEOLE; DIETHYLENE GLYCOL MONOETHYL ETHER; LIMONENE; LIPOSOME; MACROGOL; METHYLCELLULOSE; OLEIC ACID; PLACEBO; POLYVINYL ALCOHOL; POVIDONE; RIZATRIPTAN; SODIUM CHLORIDE; SORBITAN LAURATE; SORBITOL; SUMATRIPTAN SUCCINATE; TRIPTAN DERIVATIVE; UNCLASSIFIED DRUG; ZELRIX; ZOLMITRIPTAN;

AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; DAILY LIFE ACTIVITY; DISEASE SEVERITY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; ERYTHEMA; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INJECTION SITE REACTION; IONTOPHORESIS; MAXIMUM PLASMA CONCENTRATION; MIGRAINE; NAUSEA AND VOMITING; NONHUMAN; PATIENT ATTITUDE; PRESCRIPTION; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE; TRANSDERMAL PATCH;

ACUTE DISEASE; ADMINISTRATION, CUTANEOUS; ANIMALS; CLINICAL TRIALS, PHASE III AS TOPIC; DRUG EVALUATION, PRECLINICAL; HUMANS; IONTOPHORESIS; MIGRAINE DISORDERS; SEROTONIN AGONISTS; SUMATRIPTAN; TREATMENT OUTCOME;

EID: 77953243954     PISSN: 19337213     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nurt.2010.03.005     Document Type: Article

References (21)

1. Lipton R.B., Bigal M.E., Diamond M., Freitag F., Reed M.L., and Stewart W.F. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 68 (2007) 343-349
2. Silberstein S.D. Migraine symptoms: results of a survey of self-reported migraineurs. Headache 35 (1995) 387-396
3. Silberstein S.D. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 55 (2000) 754-762
4. Jhee S.S., Shiovitz T., Crawford A.W., and Cutler N.R. Pharmacokinetics and pharmacodynamics of the triptan antimigraine agents: a comparative review. Clin Pharmacokinet 40 (2001) 189-205
5. Siegel S.J., O'Neill C., Dube L.M., et al. A unique iontophoretic patch for optimal transdermal delivery of sumatriptan. Pharm Res 24 (2007) 1919-1926
6. GlaxoSmithKline. IMITREX (sumatriptan succinate) Tablets prescribing information (2007)
7. GlaxoSmithKline. IMITREX (sumatriptan) Nasal spray prescribing information (2007)
8. GlaxoSmithKline. IMITREX (sumatriptan succinate) Injection prescribing information (2008)
9. Brown M.B., Martin G.P., Jones S.A., and Akomeah F.K. Dermal and transdermal drug delivery systems: current and future prospects. Drug Deliv 13 (2006) 175-187
10. Prausnitz M.R., and Langer R. Transdermal drug delivery. Nat Biotechnol 26 (2008) 1261-1268
11. Femenia-Font A., Balaguer-Fernandez C., Merino V., Rodilla V., and Lopez-Castellano A. Effect of chemical enhancers on the in vitro percutaneous absorption of sumatriptan succinate. Eur J Pharm Biopharm 61 (2005) 50-55
12. Femenia-Font A., Merino V., Rodilla V., and Lopez-Castellano A. High-performance liquid chromatographic determination of sumatriptan after in vitro transdermal diffusion studies. J Pharm Biomed Anal 37 (2005) 621-626
13. Femenia-Font A., Padula C., Marra F., et al. Bioadhesive monolayer film for the in vitro transdermal delivery of sumatriptan. J Pharm Sci 95 (2006) 1561-1569
14. Balaguer-Fernandez C., Femenia-Font A., Del Rio-Sancho S., Merino V., and Lopez-Castellano A. Sumatriptan succinate transdermal delivery systems for the treatment of migraine. J Pharm Sci 97 (2008) 2102-2109
15. Femenia-Font A., Balaguer-Fernandez C., Merino V., and Lopez-Castellano A. Combination strategies for enhancing transdermal absorption of sumatriptan through skin. Int J Pharm 323 (2006) 125-130
16. Femenia-Font A., Balaguer-Fernandez C., Merino V., and Lopez-Castellano A. Iontophoretic transdermal delivery of sumatriptan: effect of current density and ionic strength. J Pharm Sci 94 (2005) 2183-2186
17. Patel S.R., Zhong H., Sharma A., and Kalia Y.N. In vitro and in vivo evaluation of the transdermal iontophoretic delivery of sumatriptan succinate. Eur J Pharm Biopharm 66 (2007) 296-301
18. Pierce M., Marbury T., O'Neill C., Siegel S., Du W., and Sebree T. Zelrix: a novel transdermal formulation of sumatriptan. Headache 49 (2009) 817-825
19. Goldstein J., Pugach N., Smith T., Nett R., Angelov A., and Pierce M. Acute anti-migraine efficacy and tolerability of Zelrix, a novel iontophoretic transdermal patch of sumatriptan. Cephalalgia 29 Suppl 1 (2009) 20
20. Garg T., Jain S., Singh H.P., Sharma A., and Tiwary A.K. Elastic liposomal formulation for sustained delivery of antimigraine drug: in vitro characterization and biological evaluation. Drug Dev Ind Pharm 34 (2008) 1100-1110
21. Patel S.R., Zhong H., Sharma A., and Kalia Y.N. Controlled non-invasive transdermal iontophoretic delivery of zolmitriptan hydrochloride in vitro and in vivo. Eur J Pharm Biopharm 72 (2009) 304-309